Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19

NCT04362189 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped No need to continue with the availability of the COVID-19 VACCINE

Conditions

COVID-19

Interventions

BIOLOGICAL: HB-adMSC
OTHER: Placebo

Sponsor

Hope Biosciences Research Foundation

Collaborators

[object Object]
[object Object]